Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$69.83
+1.28%today
MKT CAP
$4.2B
+5.2% · 1Y
Earnings History
+15.8%
-6.4%
-5.0%
+26.9%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$69.83
Low
$100.00
Analyst Mean
$142.17
High
$200.00
12 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-24.8x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership1.4%
Institutional Ownership92.6%
Short % of Float18.79%
Days to Cover4.9d
1 Week-12.0%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SANDLER LAURA LEE | Chief Operating Officer | Sale | 5,000 | $62.58 | $0.32M | 2026-05-01 |
| SANDLER LAURA LEE | Chief Operating Officer | Conversion | 5,000 | $7.80 | $0.04M | 2026-05-01 |
| GONCALVES JOANA | Officer | Sale | 7,000 | $65.73 | $0.46M | 2026-04-15 |
| GONCALVES JOANA | Officer | Conversion | 7,000 | $6.84 | $0.05M | 2026-04-15 |
| QUINLAN PAUL T | General Counsel | Sale | 733 | $41.30 | $0.03M | 2026-03-16 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| FMR, LLC | institution | 14.47% | $0.51B | +0.05% | 2025-12-31 |
| VR Adviser, LLC | institution | 8.26% | $0.29B | +0.00% | 2025-12-31 |
| Fairmount Funds Management LLC | institution | 7.38% | $0.26B | +0.00% | 2025-12-31 |
| Blackrock Inc. | institution | 7.05% | $0.25B | +60.55% | 2025-12-31 |
| Viking Global Investors, L.P. | institution | 5.31% | $0.19B | +0.00% | 2025-12-31 |
| Vanguard Group Inc | institution | 4.89% | $0.17B | +38.10% | 2025-12-31 |
| Deep Track Capital, Lp | institution | 4.31% | $0.15B | -18.58% | 2025-12-31 |
| RTW Investments LP | institution | 4.10% | $0.14B | +5.78% | 2025-12-31 |
| Commodore Capital Lp | institution | 3.49% | $0.12B | +0.00% | 2025-12-31 |
| Paradigm Biocapital Advisors LP | institution | 3.41% | $0.12B | +100.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.73% | $0.10B | +28.82% | 2025-12-31 |
| Fidelity Select Portfolios-Select Health Care Portfolio | fund | 2.01% | $0.07B | +0.57% | 2026-02-28 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.87% | $0.07B | -0.16% | 2026-03-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 1.59% | $0.06B | +24.31% | 2026-03-31 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | fund | 1.42% | $0.05B | +0.00% | 2026-03-31 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | fund | 1.12% | $0.04B | -6.67% | 2026-03-31 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | fund | 1.10% | $0.04B | +0.00% | 2026-02-28 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | fund | 0.95% | $0.03B | -32.51% | 2026-02-28 |
| T. Rowe Price Health Sciences Fund, Inc. | fund | 0.92% | $0.03B | +88.34% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.85% | $0.03B | +30.74% | 2025-12-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for ORKA.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.